In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Latest From AbbVie Inc.

Jazz Hits High Note With Updated Zanidatamab Data In Biliary Tract Cancer At ASCO

The company said it is in talks with the US FDA for an accelerated approval filing of the HER2-directed bispecific antibody, which showed better ORR and PFS than the standard of care.

ASCO Cancer

US FDA’s June User Fee Calendar Starts Out Steady, But A Crescendo Of Decisions Will Start Mid-Month

Two gene therapies and two novel inhibitors of JAK kinases are among the upcoming goal dates from the Pink Sheet’s US FDA Performance Tracker.

US FDA Performance Tracker Drug Approval Standards

Health And Wellness Executive Decisions: NIH ODS Director, B+L Consumer Chief, Herbalife, More

Army Institute Performance Division physiologist leads NIH ODS; Ferris heads B+L consumer products; medical director For HumanN supplements; and Herbalife scores Ronaldo sponsorship extension.

Executive Changes Consumer

Claritin Liqui-Gels' Label ‘Refresh’ Loses Blue Sky

Changes replace blue background used across Claritin line with white above navy blue waves. Brand’s still printed in white text, but in letters with blue shadow; other package-front text is in red or green instead of yellow.

Approvals OTC Drugs
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Other Names / Subsidiaries
    • Luminera
    • Mavupharma
    • Pharmacyclics, Inc.
    • Stemcentrx, Inc.
    • Syndesi Therapeutics SA
UsernamePublicRestriction

Register